Editorial: anti‐TNF therapy and myopenia in Crohn's disease—another step towards personalised medicine

Abstract

Linked Content This article linked to Ding et al papers. To view these articles visit https://doi.org/10.1111/apt.14293 and https://doi.org/10.1111/apt.14409.

Editorial: anti‐TNF therapy and myopenia in Crohn's disease—another step towards personalised medicine. Authors’ reply

“…We thank Dr Murray for his insightful editorial on our retrospective cohort study examining body composition parameters and their associations with anti‐TNF therapy outcome . As the therapeutic targets for Crohn's disease are still limited, it is vital to unravel the many causes of primary nonresponse and secondary loss of response to current biologic therapies.…”